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Relevance of Monocytic Features for Neovascularization
Capacity of Circulating Endothelial Progenitor Cells
Carmen Urbich, PhD*; Christopher Heeschen, MD*; Alexandra Aicher, MD; Elisabeth Dernbach, MD;
Andreas M. Zeiher, MD; Stefanie Dimmeler, PhD
Background—Transplantation of ex vivo expanded circulating endothelial progenitor cells (EPCs) from peripheral blood
mononuclear cells improves the neovascularization after critical ischemia. However, the origin of the endothelial
progenitor lineage and its characteristics have not yet been clearly defined. Therefore, we investigated whether the
phenotype and functional capacity of EPCs to improve neovascularization depend on their monocytic origin.
Methods and Results—Monocytic CD14 cells were isolated from mononuclear cells and incubated on fibronectin-coated
dishes in endothelial medium in the presence of vascular endothelial growth factor. After 4 days of cultivation, adherent
cells deriving from CD14 or CD14 mononuclear cells showed equal expression of endothelial marker proteins and
capacity for clonal expansion as determined by measuring endothelial colony-forming units. In addition, transplanted
EPCs (5105 cells) deriving from CD14 or CD14 cells were incorporated into vascular structures of nude mice after
hind-limb ischemia and significantly improved neovascularization from 0.270.12 (no cells) to 0.660.12 and
0.650.17, respectively (P0.001; laser Doppler–derived relative blood flow). In contrast, no functional improvement
of neovascularization was detected when freshly isolated CD14 mononuclear cells without ex vivo expansion were
used (0.330.17). Moreover, macrophages or dendritic cells differentiated from isolated CD14 cells were significantly
less effective in improving neovascularization than EPCs cultivated from the same starting population (P0.01).
Conclusions—These data demonstrate that EPCs can be generated from nonmonocytic CD14 peripheral blood
mononuclear cells and exhibit a unique functional activity to improve neovascularization after hind-limb ischemia.
(Circulation. 2003;108:2511-2516.)
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Improvement of neovascularization after critical ischemia isan important novel therapeutic strategy. Growth of new
blood vessel in the adult occurs through arteriogenesis,
angiogenesis or vasculogenesis.1 Arteriogenesis is defined as
the growth of collateral vessels, whereas angiogenesis refers
to the growth of new capillaries by sprouting of preexisting
vessels through migration and proliferation of mature
endothelial cells (ECs). The concept of vasculogenesis was
originally described by Sabin2 and others,3,4 who investi-
gated the embryonic de novo blood vessel formation and
assigned the term “angioblast” to the endothelial cell
precursor. Now, the term “vasculogenesis” is also used to
describe adult blood vessel formation, referring to the
mobilization of bone marrow– derived endothelial stem
cells, which home to sites of ischemia and contribute to
new blood vessel formation.1 The finding that vasculogen-
esis also contributes to blood vessel formation in the adult
offers novel therapeutic strategies for the use of cultivated
circulating endothelial progenitor cells (EPCs) or their
precursors for cell therapy of tissue ischemia.5– 8
EPC populations can be grown from mononuclear cells
(MNCs) or purified populations of CD34-positive or
CD133-positive hematopoietic cells.9,10 In addition, CD14-
positive MNCs have been used as the starting population
for cultivation of EPCs.11 Cultivated EPCs grown from
different starting populations, including peripheral blood
MNCs, have been shown to express endothelial marker
proteins such as von Willebrand factor (vWF), vascular
endothelial growth factor (VEGF)-receptor 2 (KDR), VE-
cadherin, CD146, and CD31.7,9,12 Moreover, these cells
were identified by their functional capacity to form EC
colonies and enhanced eNOS expression after shear-stress
exposure.13–15 Various studies have demonstrated that
MNC– derived EPCs improve neovascularization after crit-
ical ischemia in animal models of hind-limb ischemia and
myocardial infarction.7,16 –18 Moreover, a recent clinical
study suggests that intracoronary infusion of blood-derived
EPCs can be used to improve coronary flow reserve and
cardiac function in patients after acute myocardial
infarction.8
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Although there is convincing evidence for the improvement
of neovascularization by EPC transplantation, the origin of the
endothelial progenitor lineage and its characterization is not
clear. Monocytic cells and the attraction of monocytic cells by
monocyte chemoattractant protein-1 have been shown to en-
hance arteriogenesis (collateral growth).19,20 In addition, a recent
study suggests that MNC-derived EPCs have monocytic char-
acteristics.21 Therefore, we investigated whether the neovascu-
larization capacity of EPCs is dependent on their monocytic
origin. Our results demonstrate that EPCs can be cultivated from
purified populations of both CD14-positive and CD14-negative
cells. EPCs derived from both subpopulations showed equal
expression of endothelial marker proteins and functional activity
for improving neovascularization in a hind-limb ischemia
model. Of note, whereas EPCs cultivated from CD14-positive
cells effectively improved neovascularization, infusion of
freshly isolated CD14-positive or CD14-negative cells did not
exhibit any therapeutic effect. These data suggest that EPCs can
be differentiated ex vivo from nonmonocytic lineages out of
peripheral blood.
Methods
Materials
Human recombinant VEGF, macrophage-colony stimulating factor
(M-CSF), granulocyte-macrophage colony-stimulating factor (GM-
CSF), and interleukin-4 were purchased from Peprotech EC Ltd.
Cell Culture
MNCs were isolated by density-gradient centrifugation with Ficoll
from peripheral blood of healthy human volunteers as described by
Dimmeler et al.12 Immediately after isolation, total MNCs (8106
cells/mL medium; cell density, 2.5106 cells/cm2) were plated on
culture dishes coated with human fibronectin (Sigma) and main-
tained in endothelial basal medium (EBM; CellSystems) supple-
mented with EGM SingleQuots, VEGF (100 ng/mL), and 20% FCS.
CD14-positive monocytes were purified from MNCs by positive
selection with anti-CD14 microbeads (Miltenyi Biotec) using a
magnetic cell sorter device (Miltenyi Biotec). Purity assessed by
fluorescence-activated cell sorting (FACS) analysis was 95%.
CD14-positive monocytes were incubated in RPMI with 10% FCS
in the presence of M-CSF (50 ng/mL) to induce macrophage
differentiation or GM-CSF (100 ng/mL) and interleukin-4 (50
ng/mL) to stimulate dendritic differentiation.
Dil-Ac-LDL–Lectin Staining
Cells were incubated with 2.4 g/mL 1,1-dioctadecyl-3,3,3,3-tet-
ramethylindocarbocyanine–labeled acetylated LDL (Dil-Ac-LDL)
(Harbor Bio-Products) in fresh medium for 1 hour. Cells were fixed
in 2% paraformaldehyde and counterstained with FITC-labeled
lectin from Ulex europaeus (Sigma).
Colony Assay
After 4 days of culture, adherent cells were washed twice with PBS
and detached with EDTA. Freshly isolated total MNCs, CD14-
positive, or CD14-negative cells were washed with PBS. Cells (each
5104) were seeded in methylcellulose plates (Methocult GF H4434,
CellSystems) with 100 ng/mL human recombinant VEGF. Plates
were studied under phase-contrast microscopy, and colonies were
counted after 14 days of incubation by 2 independent investigators.
Colonies that took up Dil-Ac-LDL and bound lectin were defined as
colony-forming unit (CFU)-ECs.22
FACS Analysis
Adherent cells were washed twice with PBS, detached with EDTA,
washed in PBS, and incubated in PBS/1% BSA in the presence of the
following antibodies. Staining of KDR (Reliatech), vWF (Onco-
gene), and CD105 (Neomarkers) was visualized with FITC-
conjugated rabbit anti-mouse immunoglobulins (Dako) or swine
anti-rabbit immunoglobulins (Dako). CD45 and CD14 (all BD
Biosciences) were used directly FITC- or PE-conjugated.
Murine Model of Hind-Limb Ischemia
The therapeutic potential of different cell types was investigated in a
murine model of hind-limb ischemia in 8- to 10-week-old female
athymic NMRI nude mice (The Jackson Laboratory, Bar Harbor,
ME). Briefly, the proximal femoral artery including the superficial
and the deep branch as well as the distal saphenous artery were
ligated with 6-0 silk suture. EPCs cultivated from MNCs, CD14-
positive, or CD14-negative cells, freshly isolated CD14-positive or
CD14-negative cells, and monocyte (CD14)-derived macrophages
and dendritic cells were injected intravenously 24 hours after
induction of hind-limb ischemia (n5; each 5105 cells/mouse).
Limb Perfusion
Two weeks after induction of ischemia, ischemic (right)/normal (left)
limb blood flow ratio was measured by laser Doppler imager
(MoorLDI-Mark 2, Moor Instruments). After 2 recordings of laser
Figure 1. Characterization of circulating EPCs. A, Experimental
setup is shown as scheme. CD14-positive and CD14-negative
cells were purified from blood-derived MNCs by use of mag-
netic beads. Equal numbers of CD14-positive, CD14-negative,
and total unfractionated MNCs were cultivated on fibronectin-
coated dishes in EBM with supplements of VEGF and 20%
FCS. After 4 days of cultivation, supernatant including suspend-
ing cells was removed and cells were washed twice. Adherent
cells were stained with Dil-Ac-LDL. CD14-positive monocytes
were incubated in RPMI with 10% FCS in presence of M-CSF
(50 ng/mL) to induce macrophage differentiation or GM-CSF
(100 ng/mL) and interleukin-4 (50 ng/mL) to stimulate dendritic
differentiation. After 4 days of cultivation, cells were stained with
Dil-Ac-LDL. Representative confocal micrographs of adherently
growing cells (EPCs, macrophages) or nonadherent DCs (cyto-
spins) are shown. B, Purity of CD14-positive and CD14-negative
populations was assessed by FACS analysis. Representative
histograms out of 5 independent experiments are shown.
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Doppler color images, the average perfusion of the ischemic and
nonischemic limbs was calculated on the basis of colored histogram
pixels.
Histological Evaluation
Capillary density was determined in 5-m frozen sections of the
adductor and semimembranous muscles. ECs were stained with
CD146-FITC (Chemicon International). Capillary density was ex-
pressed as number of capillaries per myocyte. Injected human cells
were identified by costaining for HLA class I-APC (BD Pharmingen)
and CD146-FITC (Chemicon International).
Statistical Analysis
Results for continuous variables are expressed as meanSEM.
Comparisons between groups were analyzed by t test (2-sided) or
ANOVA for experiments with more than 2 subgroups. Post hoc
range tests and pairwise multiple comparisons were performed with
the t test (2-sided) with Bonferroni adjustment. Probability values of
P0.05 were considered statistically significant. All analyses were
performed with SPSS 11.5 software (SPSS Inc.).
Results
Characterization of EPCs Cultivated From
CD14-Positive or CD14-Negative Cells
To investigate whether EPCs are derived from monocytic
cells, we purified CD14-positive and CD14-negative cells
from blood-derived MNCs by use of magnetic beads. The
experimental setup is outlined in Figure 1A. The purity of the
CD14-positive population was 95.40.7% (Figure 1B).
CD14-negative cell populations contained 3.72.7%
CD14-positive cells (Figure 1B). Equal numbers of CD14-
positive (CD14), CD14-negative (CD14), and total unfrac-
tionated MNCs were cultivated on fibronectin-coated dishes
in EBM supplemented with human epidermal growth factor,
bovine brain extract, gentamicin, hydrocortisone, VEGF, and
20% FCS to cultivate EPCs ex vivo as previously de-
scribed.7,9,12,23 After 4 days of cultivation, the supernatant
including the suspending cells was removed, and the adherent
Figure 2. Expression of endothelial
markers on EPCs. A, Total unfraction-
ated MNCs, CD14-positive, CD14-
negative, and CD14-negative/CD11b-
negative cells were cultivated on
fibronectin-coated dishes in EBM with
supplements, VEGF, and 20% FCS. After
4 days of cultivation, adherent cells were
stained with Dil-Ac-LDL and lectin. Rep-
resentative micrographs are shown. B,
Staining of KDR, CD105, vWF, and CD45
(bold lines) by FACS analysis is shown
compared with isotype controls (thin
lines); n3.
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cells were washed twice. Adherent cells grown from total
MNCs, CD14-positive, and CD14-negative cells stained positive
for Dil-Ac-LDL and lectin (Figures 1A and 2A). Moreover,
FACS or Western blot analysis revealed comparable expression
of the endothelial marker proteins KDR, CD105, endothelial
nitric oxide synthase (eNOS), and vWF (Figure 2B and data not
shown). Further cultivation up to 7 days leads to an additional
increase in KDR and eNOS expression (data not shown). Of
note, all cells expressed the panleukocyte marker protein CD45
(Figure 2B). To exclude the possibility that contaminating
CD14 cells within the CD14 fraction are the source of EPCs,
we additionally purified the CD14-negative cells with anti-
CD11b microbeads as a second monocytic marker protein.
These CD14CD11b cells (CD14 cells, 0.250.16%) also
give rise to Dil-Ac-LDL/lectin–double-positive cells after 4
days in culture (Figure 2A), thereby excluding the possibility
that adherent EPCs are deriving from contaminating monocytic
cells after the first purification step.
To demonstrate that cultivated EPCs have a proliferative
capacity and stem/progenitor cell characteristics, we per-
formed endothelial colony assays (CFU-EC) (Figure 3, A–C).
Similar numbers of CFU-ECs could be grown from EPCs
originating from CD14-positive, CD14-negative, and total
unfractionated MNCs (Figure 3C). In contrast, the number of
granulocyte/monocyte-colony forming units (CFU-GM) was
very low in all 3 experimental settings (1/plate). In contrast,
when directly incubating CD14-positive cells without previ-
ous culture, we detected predominantly CFU-GM colonies
and only a minor proportion of CFU-EC (Figure 3B).
Improvement of Neovascularization by EPCs
Growing From CD14-Positive or
CD14-Negative MNCs
To assess the functional capacity of CD14-positive, CD14-
negative, and MNC-derived EPCs, we used a hind-limb ische-
mia model. The severely impaired neovascularization of nude
mice in the control group was almost completely rescued by
intravenous infusion of human EPCs cultivated from CD14,
CD14, or total MNC as assessed by laser Doppler–monitored
blood flow measurements (Figure 4A). Interestingly, infusion of
purified CD14 cells or CD14 cells without previous culture
did not result in a functional improvement of neovascularization
(Figure 4A). Capillary density was significantly augmented by
use of cultured CD14-positive, CD14-negative or MNC-derived
EPCs but not by CD14 cells without previous incubation
(Figure 5B and data not shown). Importantly, integrated EPCs
were detected in immunohistochemical sections of the limbs
(Figure 5A). Again, the efficiency of incorporation was similar
when EPCs from CD14, CD14, or total MNCs were infused
(Figure 5A and data not shown).
Finally, we investigated whether cells that can be differ-
entiated ex vivo from CD14 monocytes, such as macro-
phages or dendritic cells, are capable of rescuing impaired
neovascularization in the hind-limb ischemia model. We
therefore differentiated, ex vivo, blood-derived CD14 mono-
cytes to macrophages or dendritic cells as described in the
Methods. However, infusion of dendritic cells did not im-
prove neovascularization after ischemia (Figure 4B). More-
over, macrophages revealed a significantly lower capacity to
improve neovascularization compared with EPCs and did not
incorporate into the vascular structures (Figures 4B and 5A).
Consistently, limb neovascularization assessed by capillary
densitometry as well as the percentage of double-positive
vessels was significantly increased in mice receiving EPCs
compared with macrophages (Figure 5, B and C).
Discussion
The data of the present study demonstrate that the origin of
EPCs isolated from peripheral blood is not restricted to the
monocytic lineage marker CD14. Thus, EPCs cultivated from
purified CD14, CD14, and total MNC fractions revealed
identical expression of endothelial marker proteins, colony
forming capacity, and functional activity as assessed by
neovascularization improvement after hind-limb ischemia.
Importantly, transplantation of freshly isolated monocytic
CD14 cells or CD14 cells without cultivation did not
rescue neovascularization after hind-limb ischemia, clearly
demonstrating that expression of the monocytic lineage
marker per se does not define a functionally active cell
population that is capable of improving neovascularization.
Obviously, different monocyte-derived cell lineages, includ-
ing macrophages and dendritic cells, can be isolated and ex
vivo expanded from blood-derived MNCs depending on the
culture conditions used. However, whereas MNC-derived ex
Figure 3. Colony-forming activity of circulating EPCs. A, Cells
were seeded in methylcellulose with VEGF (100 ng/mL). A repre-
sentative CFU-EC (left) and CFU-GM (right) is shown. B and C,
Colonies per high-power field were quantified by light micros-
copy after 14 days of cultivation. Data are meanSEM; n8.
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vivo–expanded EPCs potently improved neovascularization,
macrophages or dendritic cells derived from the identical starting
MNC population were significantly less effective in improving
new blood vessel formation. These data suggest that EPCs
generated from peripheral blood MNCs exhibit a unique func-
tional activity. Of note, EPCs not only express endothelial
markers but also stain positive for other markers, such as the
panleukocyte marker protein CD45, after 4 days of cultivation.
This observation may be rationalized with the progenitor cell
phenotype of the ex vivo–expanded cells and may be essential
for the functional activity of EPCs. Our data as well as various
previous studies show that infusion of finally differentiated
mature ECs does not improve neovascularization after ische-
mia7,17,18 (data not shown). Thus, a completely differentiated
endothelial phenotype is not suitable for cell transplantation,
although these cells can form tube-like structures in angiogenesis
assays in vitro. This might be explained by the lack of homing
receptors expressed on more mature cells.
Previous studies suggested that monocytic cells may contrib-
ute to neovascularization via the release of proangiogenic
growth factors.19,24,25 A recent publication corroborated these
earlier findings by demonstrating that cultivated MNCs, which
do not express endothelial marker proteins but are of monocytic
origin, release VEGF, hepatocyte growth factor (HGF), and
G-CSF.21 In line with these findings, we could demonstrate that
EPCs cultivated from different sources showed a marked ex-
pression of growth factors such as VEGF, HGF, and IGF-1
(C.U., unpublished data). Thus, EPCs may release a variety of
growth factors that act in a paracrine manner and contribute to
the profound angiogenic effect. However, EPCs also incorpo-
rated into the newly formed vessel structures and showed
endothelial marker protein expression in vivo. These data sug-
gest that EPCs do not act exclusively via releasing paracrine
factors. Indeed, the infusion of macrophages, which are known
to release growth factors24–28 but were not incorporated into
vessel-like structures, induced only a slight increase in neovas-
cularization after ischemia. Further studies will be necessary to
define potential factor(s) contributing to the proangiogenic
capacity of different cell sources that may be used for therapeutic
neovascularization. However, because macrophages were signif-
Figure 4. Neovascularization capacity of
EPCs. A, EPCs derived from MNCs,
CD14-positive, or CD14-negative cells or
freshly isolated CD14-positive or CD14-
negative cells (each 5105 cells; n5 or
6) were injected intravenously into a
murine model of hind-limb ischemia.
Representative laser Doppler images
obtained 2 weeks after induction of hind-
limb ischemia are shown. Perfusion sig-
nal is subdivided into 6 different inter-
vals, each displayed as a separate color.
Low or no perfusion is displayed as dark
blue; highest perfusion interval is dis-
played as red. Quantitative results are
presented as medians, with box plots
representing 25th and 75th percentiles
as boxes and 5th and 95th percentiles
as whiskers. B, EPCs, macrophages
(M), or dendritic cells (DC; each 5105
cells; n5 or 6) were injected intrave-
nously into a murine model of hind-limb
ischemia. Representative laser Doppler
images obtained 2 weeks after induction
of hind-limb ischemia are shown. Results
are presented as medians, with box
plots representing 25th and 75th percen-
tiles as boxes and 5th and 95th percen-
tiles as whiskers.
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icantly less effective in promoting neovascularization after
hind-limb ischemia, the capacity of EPCs to physically contrib-
ute to vessel-like structures may contribute significantly to their
potent capacity to improve neovascularization.
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Figure 5. Immunohistochemistry of limb muscle sections. A,
Immunohistochemistry of limb muscle sections from nude mice
treated with human EPCs or macrophages (HLA-APC, red fluo-
rescence). Human and murine ECs were detected by anti–
CD146-FITC (green fluorescence). Double-positive cells appear
in yellow. Representative confocal images are shown. Higher
magnification is shown in lower panels. B, Capillary density is
expressed as % of control. Results are shown as box plots rep-
resenting median, 25th and 75th percentiles as boxes, and 5th
and 95th percentiles as whiskers. *P0.05 vs macrophages. C,
Incorporation of EPCs was quantified, and results are shown as
box plots representing median, 25th and 75th percentiles as
boxes, and 5th and 95th percentiles as whiskers. *P0.05 vs
macrophages.
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In the article by Leon et al, “Cardiac Rehabilitation and Secondary Prevention of Coronary Heart
Disease: An American Heart Association Scientific Statement From the Council on Clinical
Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council
on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in
Collaboration With the American Association of Cardiovascular and Pulmonary Rehabilitation,”
which appeared in the January 25, 2005, issue of the journal (Circulation. 2005;111:369–376), an
error appears on page 372. In the paragraph that begins, “Furthermore, in the presence of advanced
CAD. . .,” the last sentence of the paragraph should read, “Aerobic exercise training also may
decrease the risk of sudden cardiac death due to ventricular tachyarrhythmias by reducing
sympathetic and enhancing parasympathetic (vagal) activity, as evidenced by increased heart rate
variability and increased baroreceptor sensitivity.69–71”
The corrected version of this article is available online at http://circ.ahajournals.org/cgi/content/
full/111/3/369. (The previous version, if needed, can be accessed by selecting the “Previous
Version of This Article” link.)
DOI: 10.1161/01.CIR.0000163615.58440.7A
In the article by Lu et al, “Water Ingestion as Prophylaxis Against Syncope,” which appeared in
the November 25, 2003, issue of the journal (Circulation. 2003;108:2660–2665), Figure 4 was not
the correct figure; a duplicate of Figure 5 was inadvertently placed above the Figure 4 legend. The
correct Figure 4 appears below. Its legend was correct as originally printed. We regret this error.
DOI: 10.1161/01.CIR.0000163621.17775.A8
In the March 21, 2005, online posting of the article by Bennett et al, “The Use of Nonsteroidal
Anti-Inflammatory Drugs (NSAIDs): A Science Advisory From the American Heart Association”
(Circulation. 2005;111:1713–1716; DOI: 10.1161/01.CIR.0000160005.90598.41), the discussion
of the Adenoma Prevention with Celecoxib (APC) trial contained some unclear text about the
results of the trial. The printed version as it appears in this issue has been changed to improve
clarity, as has the online version.
DOI: 10.1161/01.CIR.0000164587.06064.83
Figure 4. Total peripheral resistance (TPR) during head-up tilt. Water ingestion accentuated the
increasing TPR during tilt-table testing. P0.001.
(Circulation. 2005;111:1717–1718.)
© 2005 American Heart Association, Inc.
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In the article by Urbich et al, “Relevance of Monocytic Features for Neovascularization Capacity
of Circulating Endothelial Progenitor Cells,” which appeared in the November 18, 2003, issue of
the journal (Circulation. 2003;108:2511–2516), the authors have identified incorrect representa-
tive laser Doppler images in Figure 4. The representative images were inadvertently mixed up
during electronic compilation of the original laser Doppler recordings for composition of the
representative figure. The quantitative data shown in the analysis are not affected because
quantitative analysis was performed using the original recordings. The corrected images for Figure
4A and 4B appear below. The authors regret this error.
DOI: 10.1161/01.CIR.0000163618.00600.26
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